note that daily dosing is only for the activation phase of the GLOW protocol (weeks 1-4) , decreasing to 5x per week for the remodeling phase (weeks 5-8), and further reduced to 2-3x per week during maintenance (weeks 9-12)
Factors such as the form of B12 used, additional ingredients, and manufacturing standards should be considered
This means its production is not regulated or reviewed by the U.S
The dosage and schedule are determined by a healthcare provider based on individual needs
Lack of Human Studies Most research has been conducted in animal models
Some people may experience a headache, dizziness, weakness, and loss of appetite, as the side effects of this medicine